logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (i) New outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates6.037.527.413.77.44.22.11.723.0358485475
Cocaine5.242.526.512.06.93.81.81.222.4263895509
Stimulants9.455.420.57.63.52.30.80.420.251241315
Hypnotics and sedatives13.123.415.511.710.39.06.610.427.02386658
Hallucinogens5.655.923.38.03.02.41.10.620.6463221
Volatile substances15.478.43.41.20.50.80.20.217.5644198
Cannabis 32.155.58.72.00.90.40.20.117.23881214521
Other substances 19.542.114.47.95.73.52.84.121.71547284
Total15.545.919.88.74.82.81.41.220.711121328181
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012